I echo that sentiment. To share another testimonial, I work in a vaccine manufacturing facility with control systems and robotics. The only reason biologics manufacturing facilities haven't been built overseas with the same zeal as other factories is the stringent requirements by the FDA, MHRA, etc. on manufacturing facilities that use live cultures. Many of the technician jobs are similarly dedicated to pushing carts and transferring components to the robots for processing. Because of the reduced efficiency of old drug discovery methods, many of these jobs are taken by college educated science majors who are finding that jobs in drug discovery research are quickly dwindling.

However, I disagree with the idea that robots are going to be able to take over in a five year timeframe.

I agree with you that the capabilities for robotics to do these tasks exist. "The future is already here - it is just unevenly distributed." I doubt however whether large manufacturing companies would be willing to shoulder the huge investments needed to develop robotics for these applications even in a healthy financial climate. Maybe this type of development could come from a company that proposes to do consulting work for manufacturing facilities, for example, Honeywell.

Additionally, I've seen that while companies see automation as an asset in pharmaceutical manufacturing, they also view it as a huge liability, as a single automation error can lead to enormous problems that take time to detect and can have huge costs, while human error generally leads to small mistakes that can be corrected and detected easily. Not sure how it is in other manufacturing subindustries.